These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 14713508

  • 21. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL, Malinin AI, Pokov AN, Hanley DF.
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [Abstract] [Full Text] [Related]

  • 22. Rationale for the use of antiplatelet drugs in patients with peripheral vascular disease.
    Violi F, Balsano F.
    Clin Trials Metaanal; 1994 Apr; 29(1):81-7. PubMed ID: 10150187
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Anticoagulation and antiaggregation in patients with peripheral arterial occlusive diseases].
    Dörffler-Melly J, Schmidli J, Mahler F.
    Ther Umsch; 2003 Jan; 60(1):36-42. PubMed ID: 12638477
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Resistance to desaggregants: causes, clinical implication, methods of diagnosis and correction].
    Kremneva LV, Shalaev SV.
    Ter Arkh; 2008 Jan; 80(12):89-95. PubMed ID: 19227916
    [No Abstract] [Full Text] [Related]

  • 30. Medical treatment of peripheral arterial disease and claudication.
    Hiatt WR.
    N Engl J Med; 2001 May 24; 344(21):1608-21. PubMed ID: 11372014
    [No Abstract] [Full Text] [Related]

  • 31. Is aspirin still the antiplatelet drug of choice for patients with peripheral arterial disease?
    Matsagas MI, Jagroop IA, Mikhailidis DP, Geroulakos G.
    Eur J Vasc Endovasc Surg; 2003 Mar 24; 25(3):281-2. PubMed ID: 12624855
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Effect of the acetylosalicyd acid (ASA) and ticlopidine therapy on clinical condition and parameters of blood platelets in patients with peripheral arterial occlusive disease (PAOD)].
    Leo W, Westrych R, Bissinger A, Okraszewski J, Baj Z.
    Pol Merkur Lekarski; 2007 Nov 24; 23(137):335-9. PubMed ID: 18361314
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Secondary stroke prevention according to the PRoFESS Study. What are the sequelae for practical therapy?].
    Diener C.
    MMW Fortschr Med; 2008 May 22; 150(21):7. PubMed ID: 18578065
    [No Abstract] [Full Text] [Related]

  • 36. Secondary stroke prevention set to benefit from PRoFESS trial: extended-release dipyridamole plus aspirin (Asasantin Retard) and clopidogrel share very similar benefit-risk ratio in vascular prevention.
    Cardiovasc J Afr; 2008 May 22; 19(3):165. PubMed ID: 18568182
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Peripheral arterial disease. A systemic disease extending beyond the affected extremity.
    Federman DG, Bravata DM, Kirsner RS.
    Geriatrics; 2004 Apr 22; 59(4):26, 29-30, 32 passim. PubMed ID: 15086071
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.